Latest News

Novo’s Ozempic® (semaglutide) 2 mg associated with lower risk of major adverse cardiovascular events (death, heart attack, and stroke) in adults with type 2 diabetes compared to switching to Mounjaro® (tirzepatide), in real-world analysis

The Newly Reimagined & Renovated Embassy Suites by Hilton Orlando International Drive ICON Park Sets a New Standard for Small and Midsized Group Events

KBR Ammonia Technology Selected for One of the Largest Fertilizer Complexes in Saudi Arabia

Amcor announces Board Chair transition

Want to Drive a Giant Peanut? The PLANTERS® Brand Is Hiring

Tronox Announces Signing of a Cooperation and Investment Agreement with JX Advanced Metals to Advance Rare Earth Strategy

Alder Validates Design for Commercial Scale-Up

Atomic Raises $12.5M to Build the AI Control System for Physical Goods Companies

ISG Welcomes Former Liberty Mutual COO James MacPhee to Board of Advisors

Amplified Planning's The Externship Posts Record Growth as More Students and Career Changers Explore Financial Planning Careers